Figure 5.

Sclareol prevents locomotion deficits and over‐synchronization of striatal neurons. A) Representative tracking trace of the vehicle‐treated mouse at baseline (day 0) and at the end of the procedure (day 30). B) Same as in (A) but from a sclareol‐treated mouse. C) Relative mobility time throughout the experiment for both mouse groups. D) Relative movement velocity over time for both mouse groups. E) Z score of the calcium traces of striatal neurons from the vehicle‐treated mouse showing the neuronal activity redundancy at days 0, 1, 10, and 30. F) Same as in (E) but from striatal cells of a sclareol‐treated mouse. Data are shown as the mean ± SEM, statistics by two‐way repeated‐measures ANOVA test (C, D), n = 6 mice per group. *p<0.05, **p<0.01.